RESUMO
By reconstructing and comparing the sequence of ontogenetic (embryonic development and post-natal growth) events across species, developmental biologists have gained unique insights into the key processes underlying the evolution of modern lineages and their extinct relatives. However, despite the importance of intraspecific variation to evolutionary transformation and lineage divergence, variation in the sequence of developmental events is seldom acknowledged. Thus, how much variation or variability should be expected during ontogeny remains poorly understood and it is an open question to what extent it impacts interspecific comparisons of developmental patterns. To address this crucial question, we studied the skeletal development of the important biomedical and developmental model organism, Monodelphis domestica. We investigated cranial, forelimb, and hindlimb elements using ontogenetic sequence analysis (OSA) to quantify and assess the full range of variation and variability in the sequence of ossification. Our study documented that previously unrecognized variation exists during M. domestica ontogeny-with over 5000 sequences for the full 92 event analysis. Further, OSA revealed unexpectedly high variability (i.e., the propensity to express variation) in the sequence of ossification for the skull and across the entire skeleton. Reconstructed modal sequences were generally in agreement with previously recognized patterns, including earlier ossification of the facial skeleton and a slight offset between forelimb and hindlimb development. However, the full range of variation shows that the majority of specimens in our analysis followed developmental trajectories distinct from those recovered by prior studies. This level of variation is quite remarkable and demonstrates the importance of assessing intraspecific ontogenetic variation. By quantifying sequence polymorphism and studying how developmental variation and variability differ among species, we can clarify more precisely how developmental patterns differ among species and gain insights into how ontogeny itself evolves.
RESUMO
Lsk is a protein tyrosine kinase with homology to the COOH-terminal Src kinase (Csk). Unlike Csk that is ubiquitously expressed, Lsk has limited tissue distribution. Here we have examined the expression and regulation of Lsk and Csk in peripheral human monocytes. We have found that Lsk mRNA and protein were not expressed in resting monocytes but were induced by treatment with interleukin 4 (IL-4) or IL-13 but not by interferon gamma (IFN-gamma) or IL-2. In fact, IFN-gamma, but not IL-2, efficiently blocked Lsk induction by IL-4 or IL-13. In contrast, Csk was constitutively present in human monocytes and was upregulated by IFN-gamma but not by IL-4 or IL-13. These results suggest that despite their structural similarities, Lsk and Csk may play distinct regulatory roles in monocyte functions elicited by cytokines, with Lsk functioning specifically within the context of a Th2-type immune response.
Assuntos
Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Interleucina-13/farmacologia , Interleucina-4/farmacologia , Monócitos/enzimologia , Proteínas Tirosina Quinases/biossíntese , Proteínas Proto-Oncogênicas pp60(c-src) , Northern Blotting , Proteína Tirosina Quinase CSK , Células Cultivadas , Indução Enzimática , Humanos , Interferon gama/farmacologia , Interleucina-2/farmacologia , Monócitos/efeitos dos fármacos , Proteínas Tirosina Quinases/isolamento & purificação , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Proteínas Recombinantes/farmacologia , Homologia de Sequência de Aminoácidos , Quinases da Família srcRESUMO
The Janus family of kinases (JAKs) has been shown to be involved in the signal transduction of a number of cytokine receptors. Recently, we have cloned a novel JAK family member, JAK3, that is expressed in natural killer and activated T cells and is coupled functionally and physically to the interleukin 2 (IL-2) receptor in these cells. Here we report that JAK3 was expressed at low but detectable levels in human monocytes. In contrast, JAK3 expression was strongly induced during activation by interferon gamma (IFN-gamma) or lipopolysaccharide. Moreover, JAK3 became tyrosine phosphorylated in response to IL-2, IL-4, and IL-7 but not response to IFN-gamma or granulocyte/macrophage colony-stimulating factor. Together, these findings suggest that JAK3 is functionally important in activated monocytes and cells of the myeloid lineage and is involved in signaling responses of cytokines that use the common gamma-chain of the IL-2 receptor.
Assuntos
Regulação Enzimológica da Expressão Gênica , Interleucina-2/farmacologia , Interleucina-4/farmacologia , Interleucina-7/farmacologia , Monócitos/enzimologia , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Proteínas Tirosina Quinases/metabolismo , Transdução de Sinais/efeitos dos fármacos , Linhagem Celular , Indução Enzimática/efeitos dos fármacos , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Fatores de Crescimento de Células Hematopoéticas/farmacologia , Humanos , Interferon gama/farmacologia , Janus Quinase 3 , Lipopolissacarídeos/farmacologia , Monócitos/efeitos dos fármacos , Fosforilação , Proteínas Tirosina Quinases/genética , Proteínas Recombinantes/farmacologia , Fator de Células-TroncoRESUMO
Export of cargo from the ER occurs through the formation of 60-70nm COPII-coated vesicular carriers. We have applied serial-thin sectioning and stereology to quantitatively characterize the three-dimensional organization of ER export sites in vivo and in vitro. We find that ER buds in vivo are nonrandomly distributed, being concentrated in regional foci we refer to as export complexes. The basic organization of an export complex can be divided into an active COPII-containing budding zone on a single ER cisterna, which is adjacent to budding zones found on distantly connected ER cisternae. These budding foci surround and face a central cluster of morphologically independent vesicular-tubular elements that contain COPI coats involved in retrograde transport. Vesicles within these export complexes contain concentrated cargo molecules. The structure of vesicular-tubular clusters in export complexes is particularly striking in replicas generated using a quick-freeze, deep-etch approach to visualize for the first time their three-dimensional organization and cargo composition. We conclude that budding from the ER through recruitment of COPII is confined to highly specialized export complexes that topologically restrict anterograde transport to regional foci to facilitate efficient coupling to retrograde recycling by COPI.
Assuntos
Vesículas Revestidas/ultraestrutura , Retículo Endoplasmático/ultraestrutura , Glicoproteínas de Membrana , Proteínas Monoméricas de Ligação ao GTP , Proteínas de Saccharomyces cerevisiae , Animais , Transporte Biológico , Linhagem Celular , Vesículas Revestidas/química , Vesículas Revestidas/metabolismo , Retículo Endoplasmático/química , Retículo Endoplasmático/metabolismo , Técnica de Congelamento e Réplica/métodos , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/fisiologia , Complexo de Golgi/ultraestrutura , Guanosina 5'-O-(3-Tiotrifosfato) , Rim , Leucemia Basofílica Aguda , Proteínas de Membrana/análise , Mutação , Membrana Nuclear/ultraestrutura , Ratos , Células Tumorais Cultivadas , Proteínas de Transporte Vesicular , Vírus da Estomatite Vesicular Indiana , Proteínas do Envelope Viral/metabolismoRESUMO
COPI and COPII are vesicle coat complexes whose assembly is regulated by the ARF1 and Sar1 GTPases, respectively. We show that COPI and COPII coat complexes are recruited separately and independently to ER (COPII), pre-Golgi (COPI, COPII), and Golgi (COPI) membranes of mammalian cells. To address their individual roles in ER to Golgi transport, we used stage specific in vitro transport assays to synchronize movement of cargo to and from pre-Golgi intermediates, and GDP- and GTP-restricted forms of Sar1 and ARF1 proteins to control coat recruitment. We find that COPII is solely responsible for export from the ER, is lost rapidly following vesicle budding and mediates a vesicular step required for the build-up of pre-Golgi intermediates composed of clusters of vesicles and small tubular elements. COPI is recruited onto pre-Golgi intermediates where it initiates segregation of the anterograde transported protein vesicular stomatitis virus glycoprotein (VSV-G) from the retrograde transported protein p58, a protein which actively recycles between the ER and pre-Golgi intermediates. We propose that sequential coupling between COPII and COPI coats is essential to coordinate and direct bi-directional vesicular traffic between the ER and pre-Golgi intermediates involved in transport of protein to the Golgi complex.
Assuntos
Vesículas Revestidas/metabolismo , Retículo Endoplasmático/metabolismo , Complexo de Golgi/metabolismo , Proteínas de Membrana/metabolismo , Proteínas Monoméricas de Ligação ao GTP , Plasmídeos/metabolismo , Proteínas de Saccharomyces cerevisiae , Fator 1 de Ribosilação do ADP , Fatores de Ribosilação do ADP , Animais , Cálcio/fisiologia , Proteínas de Transporte/metabolismo , Células Cultivadas/metabolismo , Proteína Coatomer , Proteínas de Ligação ao GTP/metabolismo , Membranas Intracelulares/metabolismo , Rim/citologia , Microssomos/metabolismo , Ratos , Receptores Citoplasmáticos e Nucleares/metabolismo , Temperatura , Proteínas de Transporte Vesicular , Vírus da Estomatite Vesicular Indiana/metabolismo , Proteínas Virais/metabolismo , Receptor de Lamina BRESUMO
ER to Golgi transport requires the function of two distinct vesicle coat complexes, termed COPI (coatomer) and COPII, whose assembly is regulated by the small GTPases ADP-ribosylation factor 1 (ARF1) and Sar1, respectively. To address their individual roles in transport, we have developed a new assay using mammalian microsomes that reconstitute the formation of ER-derived vesicular carriers. Vesicles released from the ER were found to contain the cargo molecule vesicular stomatitis virus glycoprotein (VSV-G) and p58, an endogenous protein that continuously recycles between the ER and pre-Golgi intermediates. Cargo was efficiently sorted from resident ER proteins during vesicle formation in vitro. Export of VSV-G and p58 were found to be exclusively mediated by COPII. Subsequent movement of ER-derived carriers to the Golgi stack was blocked by a trans-dominant ARF1 mutant restricted to the GDP-bound state, which is known to prevent COPI recruitment. To establish the initial site of coatomer assembly after export from the ER, we immunoisolated the vesicular intermediates and tested their ability to recruit COPI. Vesicles bound coatomer in a physiological fashion requiring an ARF1-guanine nucleotide exchange activity. These results suggest that coat exchange is an early event preceding the targeting of ER-derived vesicles to pre-Golgi intermediates.
Assuntos
Vesículas Revestidas/química , Retículo Endoplasmático/química , Proteínas de Membrana/metabolismo , Microssomos/química , Proteínas Monoméricas de Ligação ao GTP , Proteínas de Saccharomyces cerevisiae , Fator 1 de Ribosilação do ADP , Fatores de Ribosilação do ADP , Animais , Transporte Biológico/fisiologia , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Células Cultivadas/metabolismo , Células Cultivadas/ultraestrutura , Vesículas Revestidas/metabolismo , Proteína Coatomer , Retículo Endoplasmático/metabolismo , Retículo Endoplasmático/ultraestrutura , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/metabolismo , Teste de Complementação Genética , Complexo de Golgi/química , Complexo de Golgi/metabolismo , Guanosina Difosfato/metabolismo , Separação Imunomagnética , Rim/citologia , Mamíferos , Proteínas de Membrana/análise , Microscopia Eletrônica , Microssomos/metabolismo , Microssomos/ultraestrutura , Mutação/fisiologia , Coelhos , Ratos , Receptores Citoplasmáticos e Nucleares/isolamento & purificação , Receptores Citoplasmáticos e Nucleares/metabolismo , Proteínas de Transporte Vesicular , Receptor de Lamina BRESUMO
Two new members (Sar1a and Sar1b) of the SAR1 gene family have been identified in mammalian cells. Using immunoelectron microscopy, Sar1 was found to be restricted to the transitional region where the protein was enriched 20-40-fold in vesicular carriers mediating ER to Golgi traffic. Biochemical analysis revealed that Sar1 was essential for an early step in vesicle budding. A Sar1-specific antibody potently inhibited export of vesicular stomatitis virus glycoprotein (VSV-G) from the ER in vitro. Consistent with the role of guanine nucleotide exchange in Sar1 function, a trans-dominant mutant (Sar1a[T39N]) with a preferential affinity for GDP also strongly inhibited vesicle budding from the ER. In contrast, Sar1 was not found to be required for the transport of VSV-G between sequential Golgi compartments, suggesting that components active in formation of vesicular carriers mediating ER to Golgi traffic may differ, at least in part, from those involved in intra-Golgi transport. The requirement for novel components at different stages of the secretory pathway may reflect the recently recognized differences in protein transport between the Golgi stacks as opposed to the selective sorting and concentration of protein during export from the ER.
Assuntos
Retículo Endoplasmático/metabolismo , GTP Fosfo-Hidrolases/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Complexo de Golgi/metabolismo , Membranas Intracelulares/metabolismo , Proteínas Monoméricas de Ligação ao GTP , Proteínas de Saccharomyces cerevisiae , Sequência de Aminoácidos , Animais , Sequência de Bases , Transporte Biológico , Células CHO , Clonagem Molecular , Sequência Consenso , Cricetinae , Primers do DNA/química , Guanosina Trifosfato/metabolismo , Células HeLa , Humanos , Ilhotas Pancreáticas/metabolismo , Glicoproteínas de Membrana/metabolismo , Dados de Sequência Molecular , Família Multigênica , Ratos , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Proteínas de Transporte VesicularRESUMO
Phylogenetic analysis with x-ray computed tomography of fossilized and recent crania implicates differential growth of the neocortex in the evolution and development of the mammalian middle ear. In premammalian tetrapods, the middle ear evolved as a chain of bones attached to the mandible and cranium, but in adult mammals the chain is detached from the mandible and lies behind it. The neocortex evolved concurrently with detachment of the chain. In mammalian development the auditory chain arises connected to the mandible but later detaches, recapitulating the phylogenetic transformation. In modern didelphid development, the auditory chain reaches mature size by the third week after birth and is then separated from the jaw and displaced caudally as the neocortex grows for another 9 weeks.
Assuntos
Evolução Biológica , Córtex Cerebral/anatomia & histologia , Orelha Média/anatomia & histologia , Mamíferos/anatomia & histologia , Crânio/anatomia & histologia , Animais , Córtex Cerebral/crescimento & desenvolvimento , Ossículos da Orelha/anatomia & histologia , Ossículos da Orelha/crescimento & desenvolvimento , Orelha Média/diagnóstico por imagem , Orelha Média/crescimento & desenvolvimento , Mamíferos/crescimento & desenvolvimento , Mandíbula/anatomia & histologia , Mandíbula/crescimento & desenvolvimento , Morfogênese , Osteogênese , Filogenia , Prosencéfalo/anatomia & histologia , Prosencéfalo/crescimento & desenvolvimento , Crânio/diagnóstico por imagem , Crânio/crescimento & desenvolvimento , Tomografia Computadorizada por Raios XRESUMO
Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the molecular basis for its antitumor activity is unknown. Similar to a number of intercalative antitumor drugs and nonintercalative epipodophyllotoxins (VP-16 and VM-26), adriamycin has been shown to induce single- and double-strand breaks in DNA. These strand breaks are unusual because a covalently bound protein appears to be associated with each broken phosphodiester bond. In studies in vitro, mammalian DNA topoisomerase II mediates DNA damage by adriamycin and other related antitumor drugs.
Assuntos
DNA Topoisomerases Tipo I/farmacologia , DNA , Doxorrubicina/farmacologia , Trifosfato de Adenosina/farmacologia , Cloreto de Sódio/farmacologiaRESUMO
Syntaxins are thought to function during vesicular transport as receptors on the target membrane and to contribute to the specificity of membrane docking and fusion by interacting with vesicle-associated receptors. Here, syntaxin 5 (Syn5) was shown to be an integral component of endoplasmic reticulum-derived transport vesicles. This pool, but not the target, Golgi-associated Syn5 pool, was essential for the assembly of vesicular-tubular pre-Golgi intermediates and the delivery of cargo to the Golgi. The requirement for vesicle-associated Syn5 in transport suggests a reevaluation of the basis for operation of the early secretory pathway.
Assuntos
Retículo Endoplasmático/metabolismo , Complexo de Golgi/metabolismo , Glicoproteínas de Membrana , Proteínas de Membrana/metabolismo , Proteínas de Transporte Vesicular , Trifosfato de Adenosina/metabolismo , Animais , Anticorpos , Transporte Biológico , Proteínas de Transporte/metabolismo , Linhagem Celular , Complexo de Golgi/ultraestrutura , Lectinas de Ligação a Manose , Fusão de Membrana , Proteínas de Membrana/imunologia , Proteínas Sensíveis a N-Etilmaleimida , Organelas/metabolismo , Proteínas Qa-SNARE , Proteínas Qb-SNARE , Proteínas Qc-SNARE , Proteínas R-SNARE , Ratos , Proteínas SNARE , Vírus da Estomatite Vesicular Indiana/fisiologia , Proteínas do Envelope Viral/metabolismoRESUMO
An avian H5N1 influenza A virus (A/Hong Kong/156/97) was isolated from a tracheal aspirate obtained from a 3-year-old child in Hong Kong with a fatal illness consistent with influenza. Serologic analysis indicated the presence of an H5 hemagglutinin. All eight RNA segments were derived from an avian influenza A virus. The hemagglutinin contained multiple basic amino acids adjacent to the cleavage site, a feature characteristic of highly pathogenic avian influenza A viruses. The virus caused 87.5 to 100 percent mortality in experimentally inoculated White Plymouth Rock and White Leghorn chickens. These results may have implications for global influenza surveillance and planning for pandemic influenza.
Assuntos
Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Virus da Influenza A Subtipo H5N1 , Vírus da Influenza A/genética , Vírus da Influenza A/patogenicidade , Influenza Humana/virologia , Sequência de Aminoácidos , Animais , Linhagem Celular , Galinhas , Pré-Escolar , Surtos de Doenças , Evolução Fatal , Feminino , Genes Virais , Glicoproteínas de Hemaglutininação de Vírus da Influenza/química , Hong Kong/epidemiologia , Humanos , Vírus da Influenza A/isolamento & purificação , Influenza Aviária/virologia , Influenza Humana/epidemiologia , Masculino , Dados de Sequência Molecular , Neuraminidase/genética , Filogenia , Virulência , Replicação ViralRESUMO
Similar to its inhibitory effect on mammalian DNA topoisomerase II, the cytotoxic drug VM26 (teniposide) also interferes with the breakage-reunion reaction of Drosophila melanogaster DNA topoisomerase II. VM26 induces topoisomerase II-mediated DNA breakage in vitro and in cultured D. melanogaster cells presumably by stabilizing an enzyme-DNA cleavable complex. The drug-induced DNA breaks on D. melanogaster hsp70 genes were mapped in cultured cells using the indirect end-labeling procedure. Multiple and specific cleavage sites occurred at both the 3' and 5' ends of the hsp70 genes. A number of these cellular topoisomerase II cleavage sites mapped close to the DNase I-hypersensitive regions of the hsp70 genes. The intensities of several topoisomerase II cleavage sites changed significantly on heat shock induction. Treatment of cultured D. melanogaster cells with VM26 at 25 degrees C resulted in the stimulation of transcription of the hsp70 genes. These results suggest that inhibition of DNA topoisomerase II may lead to heat shock transcription.
Assuntos
Cromatina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Drosophila melanogaster/genética , Proteínas de Choque Térmico/genética , Animais , Dano ao DNA , Enzimas de Restrição do DNA , Drosophila melanogaster/enzimologia , Hibridização de Ácido Nucleico , Teniposídeo/farmacologiaRESUMO
The effect of antitumor epipodophyllotoxins, etoposide (VP-16) and teniposide (VM-26), on chromosomal DNA in mammalian cells was studied using SV40 virus-infected monkey cells as a model system. Treatment of SV40 virus-infected monkey cells with these drugs results in DNA breaks on intracellular SV40 DNA. The broken DNA strands are sensitive to phenol extraction, suggesting that they are associated with tightly linked protein(s). Several pieces of evidence suggest that DNA topoisomerase II is covalently linked to the broken SV40 DNA strands following drug treatment. ovobiocin, an inhibitor of topoisomerase II, blocks the epipodophyllotoxin-induced SV40 DNA breaks in vivo and in vitro. Epipodophyllotoxin-induced cleavage sites on intracellular SV40 DNA are strikingly similar to those produced on purified SV40 DNA by purified calf thymus DNA topoisomerase II. The protein-linked SV40 DNA is specifically immunoprecipitated by antisera against topoisomerase II. We thus conclude that epipodophyllotoxins induce chromosomal DNA breakage via DNA topoisomerase II. The physiological effects of epipodophyllotoxins on cell death, chromosomal DNA breakage, sister chromatid exchanges, and chromosomal aberrations may be the consequence of drug interaction with DNA topoisomerase II. Our present results are also consistent with the proposal that epipodophyllotoxins interfere with the breakage-reunion reaction of DNA topoisomerase II by stabilizing an enzyme-DNA complex in its putative cleavable state.
Assuntos
DNA Topoisomerases Tipo II/fisiologia , Etoposídeo/farmacologia , Podofilotoxina/análogos & derivados , Animais , Células Cultivadas , Precipitação Química , DNA Topoisomerases Tipo II/imunologia , DNA Viral/análise , Haplorrinos , Novobiocina/farmacologia , Vírus 40 dos Símios , Teniposídeo/farmacologiaRESUMO
Antitumor drugs from many chemical classes have been shown to induce protein-linked DNA breaks in cultured mammalian cells and in vitro in the presence of purified mammalian DNA topoisomerase II. The possibility that mammalian DNA topoisomerase II is an intracellular target which mediates drug-induced DNA breaks is supported by the following studies using 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA): (a) a single m-AMSA-dependent DNA cleavage activity copurified with calf thymus DNA topoisomerase II activity at all chromatographic steps of the enzyme purification; (b) m-AMSA-induced DNA cleavage by this purified activity resulted in the covalent attachment of protein to the 5'-ends of the DNA via a tyrosyl phosphate bond. This covalently linked protein has the same reduced molecular weight as purified calf thymus DNA topoisomerase II. The possibility that topoisomerase II-mediated DNA breaks may be responsible for cytotoxicity has also been investigated using a number of m-AMSA-related acridines. The level of topoisomerase II-mediated DNA breaks in vitro strongly correlates with the level of protein-linked DNA breaks in cultured cells and drug-induced cytotoxicity. These results suggest that mammalian DNA topoisomerase II may be a cytotoxic target of antitumor acridines.
Assuntos
Acridinas/farmacologia , Aminoacridinas/farmacologia , Antineoplásicos/farmacologia , DNA Topoisomerases Tipo II/fisiologia , DNA/metabolismo , Amsacrina , Animais , Bovinos , Reparo do DNA , Camundongos , Ácido Nalidíxico/farmacologia , Radioisótopos de Fósforo , TirosinaRESUMO
Epipodophyllotoxins are an important new class of anticancer agents which include the compounds VM-26 (teniposide) and VP-16 (etoposide). The mechanism of action of these drugs appears to involve production of DNA single- and double-strand breaks by virtue of a temperature-sensitive interaction between drug and a heat-labile intranuclear component. We now report evidence indicating that type II topoisomerase is the likely intracellular target for the DNA strand-breaking effects of the epipodophyllotoxins. Both VM-26 and VP-16 stimulate site-specific DNA cleavage by a highly purified calf thymus type II topoisomerase. VM-26 is 5- to 10-fold more potent than VP-16 in this assay, a difference that is also seen when DNA strand breaks are assayed in isolated nuclei of mouse leukemia cells following drug exposure. Furthermore, a similar potency difference exists with respect to cytotoxicity. Equilibrium dialysis experiments using [3H]VP-16 indicate that the drug does not bind to DNA. Thus, we suggest that the epipodophyllotoxins exert their anti-cancer effects by "poisoning" type II topoisomerase without binding to DNA. In this regard, their actions may be analogous to those of nalidixic acid in bacteria.
Assuntos
DNA Topoisomerases Tipo II/metabolismo , DNA de Neoplasias/metabolismo , Leucemia L1210/patologia , Podofilotoxina/toxicidade , Animais , Bovinos , Núcleo Celular/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Etoposídeo/toxicidade , Leucemia L1210/metabolismo , Camundongos , Relação Estrutura-Atividade , Teniposídeo/toxicidade , Timo/enzimologiaRESUMO
Tumor necrosis factor has traditionally been thought to have direct cytostatic and cytotoxic properties with little or no direct immunomodulatory activity. We report here that tumor necrosis factor is able to activate macrophages both in vitro and in vivo and can increase a mixed lymphocyte response and act as an adjuvant for both T- and B-cells in vivo. Adjuvant activity in T-cells occurred in conjunction with the administration of a suboptimal syngeneic tumor cell vaccine. In addition, tumor necrosis factor demonstrated a potent dose-dependent effect on bone marrow stem cell number, dramatically depressing cellularity and thus total stem cell number. An appreciable interval is required for recovery from such stem cell depletion. Therefore, the study of the therapeutic activity of tumor necrosis factor must include a consideration of its immunomodulatory properties.
Assuntos
Formação de Anticorpos/efeitos dos fármacos , Imunidade Celular/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia , Adjuvantes Imunológicos , Animais , Linfócitos B/efeitos dos fármacos , Células da Medula Óssea , Citotoxicidade Imunológica/efeitos dos fármacos , Células-Tronco Hematopoéticas/efeitos dos fármacos , Células Matadoras Naturais/efeitos dos fármacos , Ativação Linfocitária/efeitos dos fármacos , Linfotoxina-alfa/farmacologia , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Camundongos , Proteínas Recombinantes/farmacologia , Linfócitos T/efeitos dos fármacosRESUMO
Spontaneous glutamate release in the supraoptic nucleus is modulated by a number of inhibitory G protein coupled receptors (GPCR), including GABAB , adenosine A1 and group III metabotropic glutamate receptors (mGluR). It remains unclear whether they have distinct roles or are redundant mechanisms that protect from hyperexcitation. To address this question, we facilitated spontaneous glutamate release using nifedipine or forskolin, which act in a protein kinase A (PKA)-independent and -dependent manner, respectively, and tested the effects of inhibitory GPCR agonists. We found that a GABAB receptor (GABAB R) agonist specifically inhibited forskolin-induced miniature excitatory postsynaptic currents (mEPSC), in contrast to an adenosine A1 receptor (A1R) agonist, which specifically inhibited nifedipine-induced mEPSCs. This suggests that GABAB Rs and A1 Rs modulate independent mechanisms activated by forskolin and nifedipine, respectively. However, the inhibitory effects of GABAB R and A1 R agonists on basal mEPSCs occluded each other, suggesting that these receptors also have an overlapping role. Group III mGluRs appear to have a greater control over glutamate release because agonists to these receptors inhibited both nifedipine- and forskolin-induced mEPSCs. mEPSCs induced by norepinephrine had the same characteristics as those induced by forskolin [i.e. PKA-dependence and sensitivity to GABAB R and group III mGluR agonists, but not an A1 R agonist]. In summary, the present study highlights the differential effects of GABAB R, A1 R and mGluR agonists on glutamate release stimulated by different secretagogues, including the endogenous neuromodulator norepinephrine. These results suggest that the roles of these inhibitory GPCRs are not completely redundant, and also indicate the physiological implications of having different excitatory and inhibitory GPCRs on the same synapse.
Assuntos
Terminações Pré-Sinápticas/metabolismo , Receptores Acoplados a Proteínas G/fisiologia , Núcleo Supraóptico/metabolismo , Agonistas do Receptor A1 de Adenosina/farmacologia , Animais , Colforsina/antagonistas & inibidores , Colforsina/farmacologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Agonistas dos Receptores de GABA-B/farmacologia , Ácido Glutâmico/metabolismo , Masculino , Potenciais Pós-Sinápticos em Miniatura/efeitos dos fármacos , Potenciais Pós-Sinápticos em Miniatura/fisiologia , Nifedipino/antagonistas & inibidores , Nifedipino/farmacologia , Norepinefrina/antagonistas & inibidores , Norepinefrina/farmacologia , Ratos , Núcleo Supraóptico/efeitos dos fármacosRESUMO
Numerous drugs are known to deplete mitochondrial DNA (mtDNA) from mammalian cells. These include DNA polymerase gamma and type II topoisomerase inhibitors, lipophilic cationic compounds, and DNA intercalating and non intercalating agents. The effects of these drugs on mtDNA metabolism will be discussed and potential mechanisms underlying their depletion of mtDNA presented.
Assuntos
DNA Mitocondrial/efeitos dos fármacos , Sistemas de Liberação de Medicamentos/métodos , Inibidores da Síntese de Ácido Nucleico , Inibidores da Topoisomerase I , Animais , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/química , Anti-Infecciosos Locais/administração & dosagem , Anti-Infecciosos Locais/química , DNA Polimerase gama , DNA Topoisomerases Tipo I/metabolismo , DNA Mitocondrial/metabolismo , DNA Polimerase Dirigida por DNA , Dequalínio/administração & dosagem , Dequalínio/química , Fluoroquinolonas , Humanos , Substâncias Intercalantes/administração & dosagem , Substâncias Intercalantes/química , Fosforilação Oxidativa/efeitos dos fármacos , Inibidores da Transcriptase Reversa/administração & dosagem , Inibidores da Transcriptase Reversa/químicaRESUMO
A 29-week gestational age newborn male infant was found to have an echogenic mass in the 3rd ventricle by prenatal ultrasound 2 weeks prior to delivery. At delivery he was poorly responsive and had hydrocephalus and ascites. A CT scan after birth showed cerebral infarction, amorphous tissue in the left hemisphere and numerous calcifications. Despite supportive treatment he died 4 days after birth. Postmortem examination of the brain revealed marked distortion of the architecture and a supratentorial undifferentiated neoplasm consistent with a PNET. The tumor showed extensive areas of hemorrhage and necrosis and involvement of lateral and third ventricles, brain parenchyma, and meninges.
Assuntos
Neoplasias Encefálicas/patologia , Ventrículos Cerebrais/patologia , Feto/patologia , Tumores Neuroectodérmicos Primitivos/patologia , Neoplasias Encefálicas/diagnóstico por imagem , Ventriculografia Cerebral , Evolução Fatal , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Doenças do Prematuro , Masculino , Tumores Neuroectodérmicos Primitivos/diagnóstico por imagem , Diagnóstico Pré-Natal , Tomografia Computadorizada por Raios X , UltrassonografiaRESUMO
PACT is an activator of the protein kinase, PKR. Here we report the isolation and the characterization of the mouse Pact gene. It contains eight exons ranging in size from 79 to 630 bp spanning a region of 18 kb with the largest and smallest introns being 3700 and 500, respectively. The human PACT gene, as analyzed from sequence available in the GenBank database, has a very similar organization. The 5' flanking regions of both mouse and human PACT genes are devoid of TATA boxes but are rich in GC boxes. Although there are putative binding sites of numerous transcription factors on both promoters, their organizations and identities are different. For examining promoter activities, about 2 kb of DNA 5' to the transcription start sites of both genes was cloned upstream of a reporter luciferase gene. Transient transfection assays demonstrated that both promoters are strong. Deletion analyses revealed that most of the positive cis-elements lie within 400 bp upstream of the transcription start sites of both mouse and human PACT genes.